Drug intelligence / Profile preview

Tetana

Development stage
Unknown
Lead developer
Biomed-Lublin
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular, Subcutaneous
01

Overview

Tetana is an approved monovalent tetanus vaccine developed and manufactured by IBSS Biomed S.A. (Biomed-Lublin) in Poland. The vaccine contains purified tetanus toxoid, which is obtained through the formaldehyde inactivation of the tetanus toxin derived from *Clostridium tetani* bacterial cultures. The toxoid is adsorbed onto an aluminum hydroxide adjuvant to enhance the immune response. Tetana works by inducing the production of protective anti-tetanus toxin antibodies, providing active immunity against tetanus. It is indicated for the active immunization of children, adolescents, and adults, including its use in national immunization programs, as a booster dose, in unvaccinated pregnant women, and for active-passive prevention in cases of contaminated wounds at high risk of infection.

Brand names
Tetana
Other names
tetanus vaccine (adsorbed)tetanus toxoid vaccine

Beyond the preview

Go deeper on Tetana.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tetana.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call